R.K. Bio Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 77.39%
(FY 2022)
- Profit 493.85%
(FY 2022)
- Ebitda -11.77%
(FY 2022)
- Net Worth 160.63%
(FY 2022)
- Total Assets 4.53%
(FY 2022)
About R.K. Bio Technologies
The Company is engaged in the Energy And Power Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arumugam Sivaraman and Andal Arumugam serve as directors at the Company.
- CIN/LLPIN
U01119TN2004PTC054455
- Company No.
054455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at R.K. Bio Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arumugam Sivaraman  | Director | 09-Jun-2008 | Current |
| Andal Arumugam | Director | 21-Oct-2004 | Current |
Financial Performance and Corporate Structure Insights of R.K. Bio Technologies.
R.K. Bio Technologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.39% increase. The company also saw a substantial improvement in profitability, with a 493.85% increase in profit. The company's net worth Soared by an impressive increase of 160.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.K. Bio Technologies?
In 2019, R.K. Bio Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Ramachandra Sports Sciences Private LimitedActive 16 years 11 monthsArumugam Sivaraman and Andal Arumugam are mutual person
Bbp Studio Virtual Bharat Private LimitedActive 8 years 2 monthsArumugam Sivaraman is a mutual person
R.K.Powergen Private LimitedActive 24 years 7 monthsArumugam Sivaraman and Andal Arumugam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at R.K. Bio Technologies?
Unlock and access historical data on people associated with R.K. Bio Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.K. Bio Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.K. Bio Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
